Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years

被引:0
|
作者
William Fusi-Rubiano
Chandoshi Mukherjee
Mark Lane
Marie D. Tsaloumas
Nicholas Glover
Andrej Kidess
Alastair K. Denniston
Helen E. Palmer
Avinash Manna
Rupal Morjaria
机构
[1] Queen Elizabeth Hospital Birmingham,Ophthalmology Department
[2] University Hospitals Birmingham NHSFT,undefined
[3] Sandwell & West Birmingham NHS Trust,undefined
[4] Academic Unit of Ophthalmology,undefined
[5] Institute of Inflammation & Ageing,undefined
[6] University of Birmingham,undefined
来源
关键词
Diabetic Macular Oedema; Iluvien; Diabetic Retinopathy; Fluocinolone Acetonide implant;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Clinical Outcomes in Treatment of Diabetic Macular Edema with Fluocinolone Acetonide Intravitreal Implant
    West, Matthew
    Kim, Samuel
    Khanifar, A. A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [22] Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review (vol 47, pg 31, 2018)
    Massa, H.
    Nagar, A. M.
    Vergados, A.
    Dadoukis, P.
    Patra, S.
    Panos, G. D.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (02) : 1099 - 1099
  • [23] Challenging Clinical Cases - A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)
    Pessoa, Bernardete
    Melo-Beirao, Joao
    Meireles, Angelina
    Meneres, Pedro
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2020, 13 : 437 - 448
  • [24] Real-Life Results after the Administration of a Single 0.19 mg Fluocinolone Acetonide (ILUVIEN®) Implant in Patients with Refractory Diabetic Macular Edema
    Darwisch, Warda
    della Volpe-Waizel, Maria
    Roberts, Philipp K.
    Boden, Karl T.
    Szurman, Peter
    Rickmann, Annekatrin
    OPHTHALMIC RESEARCH, 2024, 67 (01) : 600 - 610
  • [25] Clinical Effectiveness of the 0.19-mg Fluocinolone Acetonide (FAc) Intravitreal Implant for Diabetic Macular Edema: Anatomic, Visual and Treatment Burden Outcomes
    Morozova, Christine
    Humayun, Lucas
    Tabandeh, Homayoun
    Boyer, David S.
    Dayani, Pouya N.
    Rahhal, Firas M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [26] Real-world clinical outcomes after sustained delivery of the 0.19 mg fluocinolone acetonide (FAc) implant for treatment of diabetic macular edema (DME)
    Godel, Sarah
    Oncel, Damla
    Donkor, Richard
    Coney, Joseph M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [27] The impact of vitrectomy on outcomes achieved with 0.19 mg fluocinolone acetonide implant in patients with diabetic macular edema
    Augustin, Albert J.
    Bopp, Silvia
    Fechner, Martin
    Holz, Frank G.
    Sandner, Dirk
    Winkgen, Andrea-M
    Khoramnia, Ramin
    Neuhann, Thomas
    Warscher, Markus
    Spitzer, Martin S.
    Sekundo, Walter
    Seitz, Berthold
    Duncker, Tobias
    Ksinsik, Christian
    Hoeh, Helmut
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (02) : 1101 - 1108
  • [28] Clinical effectiveness of the fluocinolone acetonide (FAc) implant in patients with diabetic macular oedema (DMO) - the Manchester experience.
    Walkden, Andrew
    Young, James
    Stone, Amy
    Mahmood, Sajjad
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [29] BETTER BASELINE VISION LEADS TO BETTER OUTCOMES AFTER THE 0.19-mg FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN DIABETIC MACULAR EDEMA
    Gonzalez, Victor
    Luo, Caesar
    Almeida, David R. p.
    Cutino, Antonio
    Coughlin, Brandon
    Kasper, Jonathan F.
    Kiernan, Daniel
    PALADIN Study Grp
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (08): : 1301 - 1307
  • [30] Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy
    Mário Lima-Fontes
    Mariana Leuzinger-Dias
    Ricardo Barros-Pereira
    Vítor Fernandes
    Manuel Falcão
    Fernando Falcão-Reis
    Amândio Rocha-Sousa
    Pedro Alves-Faria
    Ophthalmology and Therapy, 2023, 12 : 377 - 388